The risk of hepatic adverse events of systemic medications for psoriasis: A prospective cohort study using the BIOBADADERM registry
23/03/2022
M. Munera-Campos, M.D., O Baniandrés-Rodríguez, M.D., Ph.D. , J Vilar-Alejo, M.D. , R Rivera, M.D. , JM Carrascosa, M.D., Ph.D. , E Daudén, M.D., Ph.D. , E Herrera-Acosta, M.D., Ph.D. , A Sahuquillo-Torralba, M.D. , FJ Gómez-García, M.D. , LM Nieto-Benito , M.D. , P de la Cueva, M.D., Ph.D. , JL López-Estebaranz, M.D., Ph.D , I Belinchón, M.D., Ph.D. , M Ferrán, M.D., Ph.D. , M Alsina, M.D., Ph.D. , L Rodriguez, M.D. , G Carretero, M.D., Ph.D. , C García-Donoso, M.D. , F Ballescá, M.D. , M Llama
Descargar documento
Journal of Dermatological Treatment 2021 DOI: 10.1080/09546634.2021.1922572